An Options Play in the Face of Earnings Decay for Patterson
As the cost of health care rises -- and dental insurance is usually an add-on people are ready to forego -- the company's revenues and earnings are in decay.
Patterson is in the dental business; it supplies very basic items, from toothbrushes to chairs to the cotton balls that get shoved in your mouth during a visit to the dentist. The company has been trying to move up the product chain (into products with higher margins) through some billing and data software, but that's still a negligible part of the business.
The challenges facing this company became apparent when it reported very disappointing earnings on November 20 and the stock gapped down some 15% to the $31 level. That was the third quarter in a row that the stock responded to less-than-expected earnings with a big gap down. In the previous quarter it had recovered nicely and went on to new 52-week highs within the following two months. I don’t think this third time will be the charm, unless you are bearish, as I am.
No Smiles in Dentistry
Patterson’s business is in a declining sales mode and faces further headwinds due to shifts in insurance coverage. Simply put, as the cost of health care rises -- and dental insurance is usually an add-on people are ready to forego -- both revenues and earnings are in decay. The slowdown ranges from the recommended preventive six-month check-up, to nonessential cosmetic treatments that might come out of pocket. Exhibit A would be Align Technology (NASDAQ:ALGN), which, all mumbo jumbo aside, is basically an orthopedic braces maker. When it reported disappointing earnings in mid October, the stock got crushed with a 30% decline. It has since stabilized in the mid $25 range, but is listless. Likewise, I think Patterson, which is actually breaking back down to $34 per share as I type, will be challenged in the coming months.
Ignoring all the research that suggests that teeth can be the canary in the coal mine for predicting and preventing the spread of major organ disease, it is still treated (or not) as a secondary, non-required health issue by both insurance companies and individuals. A slowdown for dental visits (essential or otherwise) puts real pressure on practices, which tend to be small, independent operations of five to 15 people. There is little reason to purchase new chairs, lights, or even cotton balls if the cash isn’t flowing.
Even after the recent sell-off the stock trades at 19x forward earnings while analyst estimates call for just 7% earnings growth into 2013. Despite the efforts to move to higher technology services, this stock is in secular decay.
The Options Play
To get bearish on this stock I’m looking at a fairly aggressive strategy, which is referred to as a risk/reversal. In this case it is established through the sale of an out of-the-money call to help finance the purchase of an out-of-the-money put.
Specifically, I would sell the January $34 call for $0.60 and buy the January $33 put for $0.80. This is a $0.20 net debit. There is the danger that if the stock zooms higher losses could be significant due the naked call so I would use a stop loss of $34.50 for exiting the position. My downside target would be $29 per share.
Sink your teeth into this bear and we’ll see how we fare.
For more from Steve Smith, take a FREE 14-day trial to OptionSmith and get his specific options trades emailed to you along with exclusive access to his full portfolio. Learn more.
Follow the markets all day every day with a FREE 14 day trial to Buzz & Banter. Over 30 professional traders share their ideas in real-time. Learn more.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.